Podcasts about salonpas

The best biotech and pharmaceutical innovations mean nothing if they can't be protected—and protected fast. Our next guest, Josh Goldberg, is solving this challenge as co-managing partner at Nath, Goldberg & Meyer, the #1 ranked patent law firm for biotech and pharmaceutical technologies. With nearly three decades of IP law experience and a unique background as a lab researcher, Josh brings an insider's understanding of how innovation actually happens. He's helped industry leaders like Amgen, Takeda, and GlaxoSmithKline turn breakthrough treatments into patent-protected portfolios—often in under a year instead of the typical four-year timeline. Driven by a passion for focus and strategic IP timing, Josh shares his pioneering approach to biotech and pharmaceutical patent prosecution. Join us to discover how smart IP strategy drives licensing power, regulatory success, and company valuation. Let's go!Episode Highlights:Focus drives success – Companies fail by trying to do everything at once; staying deliberate and focused is key to making real impactOne-year patent timelines vs. four years – Josh uses USPTO's Track 1 program to secure patents in record time, improving fundraising and M&A positioningClient-centered approach wins – Listening to unique client needs instead of one-size-fits-all strategies earned the firm its #1 rankingDiagnostic patents are back – New USPTO Director signals the patent office is "open for business" again after a decade of restrictionsScientist turned patent attorney – Josh's lab background gives him insider understanding of how innovation actually happensAbout our Guest: Joshua is the patent attorney innovation-driven pharmaceutical companies call when they need to turn complicated technologies into protected assets in record time.As co-managing partner at Nath, Goldberg & Meyer—the #1 ranked patent law firm for biotech and pharmaceutical technologies in both 2024 and 2025—Joshua leads IP efforts across industries like biotech, pharma, agriculture, renewable energy, and advanced materials. Whether it's a blockbuster acne treatment like DUAC, a vitamin D analog lotion like Sorilux, OTC solutions like Salonpas and Germagic, or a leading drug used to reduce stomach acid and treat conditions like GERD, ulcers, and heartburn—like Protonix—Joshua helps turn high-stakes R&D into patent-protected portfolios, often in under a year instead of the typical four-year timeline.Though his climate and agricultre IP expertise has made him famous as the “green patent guy,” Joshua moves between disciplines skillfully and has helped industry leaders like Amgen, Takeda, Guilford Pharmaceuticals, Mayne, and Stiefel Laboratories (which was acquired by GlaxoSmithKline) build pharma portfolios that hold up under investor, acquirer, and FDA scrutiny.His journey didn't begin in IP law, but in the lab, researching experimental pharmaceutical delivery systems. It gave him an edge most attorneys don't have: understanding how innovation actually happens, and how to protect it without slowing a business down. Links Supporting This Episode: Nath, Goldberg & Meyer Website: CLICK HEREJoshua Goldberg LinkedIn page: CLICK HERENath, Goldberg & Meyer LinkedIn: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page:...

Golf: Saiki Fujita Leads after 1st Day of World Ladies Championship Salonpas Cup

Golf: Nasa Hataoka to Compete in JLPGA's World Ladies Championship Salonpas Cup

John Incledon, President and CEO of Hisamitsu America, the makers of Salonpas, has seen enormous growth in the acceptance of over-the-counter topical pain management options since introducing the Salonpas analgesic patch in the US market 37 years ago. This growth is partly due to television ads featuring doctors touting the benefits of Salonpas for mild to moderate nerve-related and muscle-related pain and the sampling program that aims to get doctors and patients to try out the products.   John explains, "Topical medications have only been around since the 1960s, with the introduction of the first OTC monograph by the FDA. Salonpas itself was formally introduced to the United States in 1987, so we've been around some 37 years or so as a brand in this country. And so, it's been a challenge. I'll give you a couple of fun facts: 85% of US households have a pill form of an OTC pain reliever in their house, and 30% have a topical analgesic of any sort, a cream, a roll-on, or a patch. So, there's a great disparity there. Pills remain a modality, topicals are up and coming, and I think the horizon for them is excellent." "Topicals work locally, at least OTC topical analgesics. You can wear patches and things intended to be systemic, but in this category and the products we're talking about, they're not. They're intended basically just to work below the surface of the skin. There are pain receptors that certain actives will trigger to help minimize the pain. However, they're not intended to get into the bloodstream, so by working locally and acting locally, they're generally safer than systemic analgesics."   "We have basically two mechanisms of action in our products. One is anesthetic-based and uses lidocaine, and lidocaine is going to be most appropriate to the extent that you can diagnose this if your source of pain is from aggravated nerves. So if your lower back pain is tending to move outward, say, from the spine, you want to use an anesthetic to treat that, and so, a lidocaine-based product would be best." "If it's purely muscle-related, then you're better off with our alternative formulas, which include menthol, methyl salicylate, and camphor. Methyl salicylate is an aspirin derivative, so it's categorized as a non-steroidal anti-inflammatory but topically applied, as opposed to systemically." #Salonpas #Hisamitsu #GoodMedicine #ItsGoodMedicine #PainManagement #OTC #OvertheCounterDrugs #TopicalAnalgesics us.hisamitsu Download the transcript here

John Incledon, President and CEO of Hisamitsu America, the makers of Salonpas, has seen enormous growth in the acceptance of over-the-counter topical pain management options since introducing the Salonpas analgesic patch in the US market 37 years ago. This growth is partly due to television ads featuring doctors touting the benefits of Salonpas for mild to moderate nerve-related and muscle-related pain and the sampling program that aims to get doctors and patients to try out the products.   John explains, "Topical medications have only been around since the 1960s, with the introduction of the first OTC monograph by the FDA. Salonpas itself was formally introduced to the United States in 1987, so we've been around some 37 years or so as a brand in this country. And so, it's been a challenge. I'll give you a couple of fun facts: 85% of US households have a pill form of an OTC pain reliever in their house, and 30% have a topical analgesic of any sort, a cream, a roll-on, or a patch. So, there's a great disparity there. Pills remain a modality, topicals are up and coming, and I think the horizon for them is excellent." "Topicals work locally, at least OTC topical analgesics. You can wear patches and things intended to be systemic, but in this category and the products we're talking about, they're not. They're intended basically just to work below the surface of the skin. There are pain receptors that certain actives will trigger to help minimize the pain. However, they're not intended to get into the bloodstream, so by working locally and acting locally, they're generally safer than systemic analgesics."   "We have basically two mechanisms of action in our products. One is anesthetic-based and uses lidocaine, and lidocaine is going to be most appropriate to the extent that you can diagnose this if your source of pain is from aggravated nerves. So if your lower back pain is tending to move outward, say, from the spine, you want to use an anesthetic to treat that, and so, a lidocaine-based product would be best." "If it's purely muscle-related, then you're better off with our alternative formulas, which include menthol, methyl salicylate, and camphor. Methyl salicylate is an aspirin derivative, so it's categorized as a non-steroidal anti-inflammatory but topically applied, as opposed to systemically." #Salonpas #Hisamitsu #GoodMedicine #ItsGoodMedicine #PainManagement #OTC #OvertheCounterDrugs #TopicalAnalgesics us.hisamitsu Listen to the podcast here

02-22-2024 Jim Lepis Learn more about the interview and get additional links here: https://usdailyreview.com/hisamitsu-america-marks-90-years-of-pioneering-pain-relief-with-salonpas-with-record-sales/ Subscribe to the best of our content here: https://priceofbusiness.substack.com/ Subscribe to our YouTube channel here: https://www.youtube.com/channel/UCywgbHv7dpiBG2Qswr_ceEQ

Hoje com a presença dos designers brasileiros gaúchos gaudérios (e carioca): Isabela Sabbadini, Luan de Oliveira (não o skatista) e Beatriz Gomes se juntam a Gustaverass em busca de assuntos que julgam ser importantes em meio a vasta opção de assuntos não importantes nessa liberdade libertinosamente imaculada.

Informações importantes.

Now wait a minute. Are we excited or are we excited? Not only do we have a great show and an amazing guest, but we have an announcement so thrilling we can't even contain ourselves. After a quick conversation about the magic of Salonpas™️, we welcome to The Carriage House the absolutely fabulous Caleb Hearon! You know Caleb from his incredible Twitter and IG videos (Variety included him on its "10 Comics to Watch in 2020" list, excuse me) and as a writer for the upcoming BIG MOUTH spin-off, HUMAN RESOURCES. Caleb helps us give advice on Facebook invites, how to talk about addiction recovery, and being a boy from the big city in love with a small town guy. So what's this big announcement we have? Joe Biden might call it a "big f*cking deal" if he were still allowed to swear. After months in the lab, we're SO thrilled to reveal the closest thing you'll ever get to a Negroni personally made for you by Ronna herself: it's the Negronna! In partnership with St. Agrestis in Brooklyn, we've come up with a perfectly mixed, boozey, bitter, and refreshing high-end cocktail that'll help you come out of quarantine in style. And with the absolute showstopper of a bottle it comes in, you'll be the life of any party you bring it to. We'll be drinking this in The Carriage House and on the Vineyard all summer, we can assure you! It's available for purchase on June 18th at Negronna.com, and will arrive just in time for the height of summer BBQ season. Stay tuned!

Kat & Moose talk about mishaps that happen after the age of 40, and question eating habits during this crisis. Necessity breeds invention, first responders rock and Moose reflects on some of the beauty found in sobriety. Check on your strong friends.Notes:Electronics aren’t working and it looks like Kat took a fall and has a strawberry. Things are happening to our bodies. Kat is a frequent flyer at TOA. Salonpas. Colonic.The pandemic has caused us to eat weird things. Ellen’s wife is cooking and needs a gift from Kat & Moose. Moose talks about watching CNN and Chris Cuomo’s chipped tooth. We all need Madison Reed for our hair during COVID-19. 5G may change things. Moose reflects on companies invented during the last recession. Instagram, Uber, Groupon, Slack, Venmo & Pinterest. Let’s thank our first responders. Moose thinks Kat’s home improvement mishaps are a larger message from synchronicity. Moose talks about Lauren McKowen We Are The Luckiest: The Surprising Magic Of A Sober Life.Support the show (https://www.patreon.com/katandmoose)

Mini Manual #29 checks in with two of the more important toiletries in my life: Salonpas, the pain relieving patch, and Cremo Shave Cream, the smoothest and most invigorating cream I've used in my many years of shaving.  Check out all of the Cremo products and labels at: https://cremocompany.com/ With host Mike Shafer.  If you like the show, please subscribe, review, share, and send over requests for other product manuals to: Facebook Twitter Instagram

John Incledon, President of Hisamitsu America (the makers of Salonpas patches), discusses the Centers for Disease Control's recent recommendation for physicians to consider the use of safer topical analgesics as the first line treatment for chronic pain. Visit www.hpr.fm to listen to more interviews about healthcare and research findings.

On continual improvement: "We use a methodology called Kaizen in which we regularly reflect on our success, evaluate, and look for opportunities to implement better ways of working both in the product development and the organization." John Incledon CEO and president of Hisamitsu America Corporation, the company that created the brand Salonpas topical pain treatment is interviewed by David Cogan of Eliances Heroes show amfm, and syndicated online. www.salonpas.us 

On continual improvement: "We use a methodology called Kaizen in which we regularly reflect on our success, evaluate, and look for opportunities to implement better ways of working both in the product development and the organization." John Incledon CEO and president of Hisamitsu America Corporation, the company that created the brand Salonpas topical pain treatment is interviewed by David Cogan of Eliances Heroes show amfm, and syndicated online. www.salonpas.us 

Join Ted Hicks (Dad, Husband & Son) as he moderates the #LNPShow that discusses the latest trends and game changers in parenting, technology, education, sports & product reviews. 805pm --- SalonPas (pain relief) President John Incledon (Hisamitsu America) - joins us to discuss their new over-the-counter pain relieving patch. 830pm Dan Soberberg (Dad-in-Chief) - co-authors the children's book "Elevator Jones" series with his nine year old son. 905pm CS Keys talks Super Bowl, San Diego / Oakland relocation attempts, Cam Newton & race relations. 930pm Rosalyn Ross talks about the NBA All-Star game, Binge watching, fitness and Valentines Day BEST practices.

Join Ted Hicks (Dad, Husband & Son) as he moderates the #LNPShow that discusses the latest trends and game changers in parenting, technology, education, sports & product reviews. 805pm --- SalonPas (pain relief) President John Incledon (Hisamitsu America) - joins us to discuss their new over-the-counter pain relieving patch. 830pm Dan Soberberg (Dad-in-Chief) - co-authors the children's book "Elevator Jones" series with his nine year old son.

SalonPas (pain relief) President John Incledon (Hisamitsu America) - joins us to discuss their new over-the-counter pain relieving patch. Tell us about the origins of the Hitsamitsu Pharmaceuticals? Why should consumers choose Salonpas? Pain Relief patches are NOT new? (Tiger Balm, Icy Hot, Bengay are already out there) How is SalonPas the only FDA patch? How are consumers over-using over-the-counter pain pills? Tell us about the alternative methods. I have to ask the money question-- People are concerned about what they are putting into their bodies - does SalonPas contain any types of steroids?

Join Ted Hicks (Dad, Husband & Son) as he moderates the #LNPShow that discusses the latest trends and game changers in parenting, technology, education, sports & product reviews. 805pm --- SalonPas (pain relief) President John Incledon (Hisamitsu America) - joins us to discuss their new over-the-counter pain relieving patch. 830pm Dan Soberberg (Dad-in-Chief) - co-authors the children's book "Elevator Jones" series with his nine year old son.

Join Ted Hicks (Dad, Husband & Son) as he moderates the #LNPShow that discusses the latest trends and game changers in parenting, technology, education, sports & product reviews.805pm --- SalonPas (pain relief) President John Incledon (Hisamitsu America) - joins us to discuss their new over-the-counter pain relieving patch. 830pm Dan Soberberg (Dad-in-Chief) - co-authors the children's book "Elevator Jones" series with his nine year old son. 905pm CS Keys talks Super Bowl, San Diego / Oakland relocation attempts, Cam Newton & race relations. 

Join Ted Hicks (Dad, Husband & Son) as he moderates the #LNPShow that discusses the latest trends and game changers in parenting, technology, education, sports & product reviews.805pm --- SalonPas (pain relief) President John Incledon (Hisamitsu America) - joins us to discuss their new over-the-counter pain relieving patch. 830pm Dan Soberberg (Dad-in-Chief) - co-authors the children's book "Elevator Jones" series with his nine year old son. 905pm CS Keys talks Super Bowl, San Diego / Oakland relocation attempts, Cam Newton & race relations. 

SalonPas (pain relief) President John Incledon (Hisamitsu America) - joins us to discuss their new over-the-counter pain relieving patch. Tell us about the origins of the Hitsamitsu Pharmaceuticals? Why should consumers choose Salonpas? Pain Relief patches are NOT new? (Tiger Balm, Icy Hot, Bengay are already out there) How is SalonPas the only FDA patch? How are consumers over-using over-the-counter pain pills? Tell us about the alternative methods. I have to ask the money question-- People are concerned about what they are putting into their bodies - does SalonPas contain any types of steroids?

Join Ted Hicks (Dad, Husband & Son) as he moderates the #LNPShow that discusses the latest trends and game changers in parenting, technology, education, sports & product reviews. 805pm --- SalonPas (pain relief) President John Incledon (Hisamitsu America) - joins us to discuss their new over-the-counter pain relieving patch. 830pm Dan Soberberg (Dad-in-Chief) - co-authors the children's book "Elevator Jones" series with his nine year old son. 905pm CS Keys talks Super Bowl, San Diego / Oakland relocation attempts, Cam Newton & race relations. 930pm Rosalyn Ross talks about the NBA All-Star game, Binge watching, fitness and Valentines Day BEST practices.